Literature DB >> 8370351

The anticonvulsant activity of D-cycloserine is specific for tonic convulsions.

S L Peterson1, N D Schwade.   

Abstract

D-Cycloserine has been shown to exert anticonvulsant activity in maximal electroshock seizures. The purpose of the present study was to evaluate the spectrum of D-cycloserine anticonvulsant activity using other experimental models of epilepsy. D-Cycloserine induced a dose-related decrease in the incidence of tonic convulsions induced by 120 mg/kg of pentylenetetrazol. The ED50 of D-cycloserine for the inhibition of the tonic convulsions was 109 mg/kg. The anticonvulsant activity was specific for the D-isomer at L-cycloserine (400 mg/kg) had no effect on the tonic convulsions. D-Cycloserine had no effect on the pentylenetetrazol-induced clonic convulsions induced by either 70 or 120 mg/kg pentylenetetrazol, electrically induced nonkindled hippocampal seizures or kindled amygdala seizures. D-Cycloserine had no effect on strychnine-induced tonic convulsions. These results indicate that D-cycloserine is inactive against clonic convulsions and may be active only against tonic convulsions mediated by brainstem sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370351     DOI: 10.1016/0920-1211(93)90094-n

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  4 in total

1.  The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder.

Authors:  Noa Albelda; Nitza Bar-On; Daphna Joel
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

2.  Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.

Authors:  W Löscher; P Wlaź; C Rundfeldt; H Baran; D Hönack
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 3.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

4.  Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.

Authors:  Hyejung Won; Won Mah; Eunjoon Kim
Journal:  Front Mol Neurosci       Date:  2013-08-05       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.